The Column Group
company
About
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
- 11 - 50
Highlights
Details
- Industries
- Biotechnology,Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
Investments
Number of Investments
Number of Lead Investments
18
5
The Column Group has made 18 investments. Their most recent investment was on
Nov 29, 2022, when Cajal Neuroscience raised $96M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2022
Cajal Neuroscience
|
Series A | $96M | Biotechnology | Yes |
|
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
|
May 5, 2021
Eikon Therapeutics
|
Series A | $148M | Biotechnology | Yes |
|
Mar 1, 2021
Tenaya Therapeutics
|
Series C | $106M | Biopharma | — |
|
Oct 6, 2020
A2 Biotherapeutics
|
Series B | $71.50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
